Related Experiment Video
Updated: Mar 3, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.4K
What do Key Stakeholders Think About HIV Self-Testing in Canada? Results from a Cross-Sectional Survey
N Pant Pai1, M Smallwood2, D Gulati3
1Division of Clinical Epidemiology and Infectious Diseases, Faculty of Medicine, McGill University Health Centre, Montreal, QC, Canada. Nitika.pai@mcgill.ca.
AIDS and Behavior
|April 26, 2017
Summary
HIV self-testing offers a promising way to reach undiagnosed individuals in Canada. Stakeholders support its implementation, but concerns about cost, accuracy, and linkage to care must be addressed.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Health Policy
Background:
- Human immunodeficiency virus (HIV) self-testing is an empowering alternative to facility-based testing.
- It is not currently available in Canada, limiting access for undiagnosed individuals.
- Stakeholder input is crucial for successful implementation of new health initiatives.
Purpose of the Study:
- To identify stakeholder concerns, opportunities, and challenges regarding HIV self-testing implementation in Canada.
- To gather insights from clinical providers, public health professionals, and researchers nationwide.
- To inform policy and practice for introducing HIV self-testing in Canada.
Main Methods:
- An online cross-sectional survey was distributed to stakeholders involved in HIV testing initiatives across Canada.
- A target sample size of 200 was set, with 183 responses received.
- Mixed-methods analysis, combining quantitative and qualitative data, was employed.
Main Results:
- A majority of stakeholders (70.7%) viewed HIV self-testing as a necessary investment.
- Most respondents (64.6%) believed self-tests should be available to clients, and 71.5% desired improved instructions.
- Concerns included affordability, linkage to counseling, coping with positive results, accuracy for acute HIV detection, and non-disclosure liability.
Conclusions:
- Stakeholders broadly support offering HIV self-testing to reach undiagnosed populations in Canada.
- Addressing concerns about cost, accuracy, counseling linkages, and integration into existing models is essential for widespread adoption.
- Timely action is urged for the availability of HIV self-tests to combat the epidemic.
Related Concept Videos
Sexually Transmitted Infections
1.4K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.4K
Significance Testing: Overview
12.9K
Significance testing is a set of statistical methods used to test whether a claim about a parameter is valid. In analytical chemistry, significance testing is used primarily to determine whether the difference between two values comes from determinate or random errors. The effect of a particular change in the measurement protocol, analyst, or sample itself can cause a deviation from the expected result. In the case of a suspected deviation/outlier, we need to be able to confirm mathematically...
12.9K
Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K

